New Research Paper Addressing Concerns about Generic ADHD Medication / Health Canada Up-dates on the Issue

Since 2010 CADDAC has shared our concerns about the direct substitution of methylphenidate ER-C, a generic medication, for OROS® methylphenidate (Concerta) with Health Canada. This was done through documentation, caregiver and patient survey results and several face to face meetings. A Canadian research paper reviewing data on this issue, was recently published in the Clinical…

ADHD in Education Awareness/Advocacy Campaign

2017/2018 ADHD in Education Awareness/Advocacy Campaign To better advocate for students with ADHD we need to hear from you! Download, share and post our Education Campaign Flyer  Access our Education Survey Share your Canadian Education Experiences advocacy@caddac.ca  This October, during ADHD Awareness Month, CADDAC is launching our “ADHD in Education Awareness/Advocacy Campaign” to draw greater…